Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis

Int J Rheum Dis. 2023 Nov;26(11):2119-2121. doi: 10.1111/1756-185X.14845. Epub 2023 Aug 11.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antirheumatic Agents* / adverse effects
  • Arthritis, Juvenile* / diagnosis
  • Arthritis, Juvenile* / drug therapy
  • Arthritis, Psoriatic* / diagnosis
  • Arthritis, Psoriatic* / drug therapy
  • Humans

Substances

  • secukinumab
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents